Local and Intraperitoneal Analgetics in Gynecologic Laparoscopy for Post Operative Pain Relief

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02976571

Enrollment

120

Registered

2016-11-29

Start date

2016-11-30

Completion date

2018-12-31

Last updated

2018-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Complications

Brief summary

A comparison between local and intraperitoneal analgetics to placebo, during laparoscopy, regarding post operative pain.

Detailed description

4 randomly assigned groups. Grop 1 will get sub cutaneous and intraperitoneal marcain. Grop 2 will get sub cutaneous marcaine and intraperitoneal saline. Grop 3 will get sub cutaneus saline and intraperitoneal marcaine. Grop 4 will get ub cutaneous and intraperitoneal saline

Interventions

DRUGBupivacaine

Sub cutaneous and/or Intraperitoneal Marcaine application

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Elective laparoscopy

Exclusion criteria

* Laparotomy Vaginal operations Oncologic operations Chronic use of analgetics due to pelvic pain Pregnancy Operations lasts more than 3 hours

Design outcomes

Primary

Measure	Time frame
Pain level during movement, 8 hours after laparoscopy	8 hours

Countries

Israel

Contacts

Primary ContactOhad Gluck, MD

ohadgluck@gmail.com97235028329

Backup ContactElad Barer, MD

elad.barber@gmail.com9725028329

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026